Midazolam oral spray - SUDAAlternative Names: NVD-301; SUDA-003
Latest Information Update: 22 Aug 2013
At a glance
- Originator NovaDel Pharma
- Developer SUDA
- Class Benzodiazepines; Hypnosedatives; Sleep disorder therapies; Small molecules
- Mechanism of Action GABA A receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Anxiety disorders